SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-014344
Filing Date
2023-10-17
Accepted
2023-10-17 16:42:58
Documents
2
Period of Report
2023-10-16

Document Format Files

Seq Description Document Type Size
1 form3-10172023_081051.html 3  
1 form3-10172023_081051.xml 3 1671
2 ex24-10172023_081053.htm EX-24 7056
  Complete submission text file 0001415889-23-014344.txt   10040
Mailing Address 210 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Garland J. Scott (Reporting) CIK: 0001533228 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39712 | Film No.: 231330027

Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations